Macular dystrophy leads to progressive loss of central vision and shows symptoms similar to age-related macular degeneration. Genetic screening of patients diagnosed with macular dystrophy disclosed a novel mutation in the GUCA1A gene, namely a c.526C > T substitution leading to the amino acid substitution p.L176F in the guanylate cyclase-activating protein 1 (GCAP1). The same variant was found in three families showing an autosomal dominant mode of inheritance. For a full functional characterization of the L176F mutant we expressed and purified the mutant protein and measured key parameters of its activating properties, its Ca -concentration, showed significantly higher activation rates than the wildtype (90-fold versus 20-fold) and interacted with an higher apparent affinity with its target guanylate cyclase. However, direct Ca 2þ -binding of the mutant was nearly similar to the wildtype; binding of Mg 2þ occurred with higher affinity. We performed molecular dynamics simulations for comparing the Ca 2þ -saturated inhibiting state of GCAP1
Introduction
Hereditary retinal disorders cause many different forms of retinal disease that can lead to severe visual impairment or blindness. Disease forms are often classified according to phenotype, for example, whether the peripheral retina is affected first or involve nutritional, lifestyle (smoking) or environmental factors, which in combination with aging lead to a higher risk of disease progression. Genetic and genomic studies have identified genetic risk loci and susceptibility genes that are expressed in the photoreceptor layer and its support system consisting of the retinal pigment epithelium (RPE) Bruchs membrane (BM) and the choroid. Phenotypic features of AMD can include the loss of large numbers of photoreceptors in the central macula and protein and lipid deposits in the BM or between BM and RPE (5) .
Macular dystrophy (MD) presents similar symptoms but is linked to a different set of genetic mutations and, in contrast to AMD, is monogenic and not considered multifactorial (6) . In addition, MD is a heterogeneous disease (caused by monoallelic or biallelic mutation/s in one out of many genes) with a variable age of onset (usually 5-50 years). One form of MD involves mutations in the GUCA1A gene (7), which encodes the guanylate cyclase-activating protein 1 (GCAP1) in rod and cone photoreceptor cells.
GCAP1 and its cognate GCAP2 regulate the activities of membrane bound guanylate cyclases (GC) in response to lightdependent changes of the cytoplasmic free Ca 2þ -concentration ([Ca 2þ ]) and thereby are critical factors for Ca 2þ -cGMP homeostasis in the outer segments of rods and cones (8) . Function of GCAP1 and GCAP2 is not redundant as they operate in a Ca 2þ -relay fashion (9, 10) , which is based on different molecular properties of GCAPs like, for example, differences in Ca 2þ -binding, Ca 2þ -sensitive operation, target regulation and conformational dynamics (10) (11) (12) (13) (14) . The exact activation mechanism of GCAPs on the target GC at low free [Ca 2þ ] and inhibition at high free [Ca 2þ ]
is unclear. Peshenko et al. (15) recently employed mutants of GCAP1 by inserting a phenylalanine (F) in critical amino acid positions around the 'myristoyl cavity' and found a major effect for the mutant L176F leading to a suggested 'Ca 2þ -myristoyl tug mechanism' of GCAP1 action (15) .
By genetic screening of patients diagnosed with MD we identified the novel variant c.526C > T (p.L176F) in the GUCA1A gene, which is identical to the mutant employed by Peshenko et al. (15) for investigating the intramolecular connections between the myristoyl group and Ca 2þ -sensing. The aim of the present work was to understand which cellular and molecular events lead to the MD associated with L176F substitution. We present a characterization of the clinical phenotype and investigate key molecular properties of the expressed and purified mutant protein. Molecular dynamics simulations further provide us with insight into protein dysfunction with respect to its conformational dynamics.
Results

Genetic screening and clinical evaluation of patients
Sanger sequencing of the GUCA1A gene in family 1 revealed a novel variant c.526C > T (p.L176F) which is not reported in public sequence repositories (including the ExAC database, http://exac. broadinstitute.org). Mutations in other macular dystrophy-/ cone dystrophy-related genes had been previously excluded in this family by ASPER chips and/or Sanger sequencing. The same variant was identified in family 2 upon a panel-based next-generation sequencing approach and in family 3 upon whole exome sequencing. All three families show an autosomal dominant mode of inheritance (Fig. 1) . Detailed clinical characteristics of the patients are displayed in Table 1 . Briefly, paracentral and central scotomas in the central visual field were present in all patients. Scotopic standard ganzfeld ERGs had normal amplitudes and implicit times in all patients except in patient II:1 from family 3. Photopic ERGs were reduced only in families 2 and 3. Multifocal ERGs were performed in patients from families 2 and 3 only and showed diminished central responses, whereas the outer ring averages revealed reduced amplitudes and delayed implicit times only in patient II:1 from family 3. Fundus abnormalities were typically confined to the macula (Supplementary Material, Fig. S1 ). Optical coherence tomography in families 1 and 2 revealed a thinner photoreceptor layer in the foveal area.
Functional characterization of L176F-GCAP1, activation of target GC1
Regulatory properties of L176F GCAP1 were compared with those of WT GCAP1. For this purpose, the GCAP1 target human GC1 was heterologously expressed in HEK293 cells and HEK293 cell membranes were isolated and reconstituted with purified myristoylated (m) and non-myristoylated (nm) GCAP1 variants. Basic features of GCAP1 function were preserved in the WT and the mutant, namely activating the target GC1 at low free [Ca 2þ ] and inhibiting it at increasing free [Ca 2þ ] ( Fig. 2A and B) . However, characteristic differences were observed in the IC 50 values ([Ca 2þ ] at which activation is halfmaximal) of the activation profiles: these were at 0.41 6 0.05 mM free [Ca 2þ ] for mWT GCAP1 and shifted to 7.09 6 1.4 mM [Ca 2þ ] for mL176F-GCAP1 (Table 2) . A different and less pronounced effect was seen with nmGCAP1 forms. Here, activation of human GC1 with WT GCAP1 was halfmaximal at an IC 50 of 0.67 6 0.18 mM [Ca 2þ ]; the L176F substitution in nmGCAP1 caused a slight shift to lower free [Ca 2þ ] at of 0.55 6 0.06 mM (Fig. 2 and Table 2 ). These results were broadly consistent with those reported by Peshenko et al. (15) , although the shift in Ca 2þ -sensitivity (IC 50 -value), which we observed for the L176F mutant was more than 17-fold, whereas Peshenko et al. observed a shift of about 8-fold. A second feature concerning the activation properties of GCAP1 is the apparent affinity for the target GC1. An indirect way to measure apparent affinity values is GC1 activation as a function of the GCAP1 concentration resulting in EC 50 values. The apparent affinity expressed in EC 50 values was highest for mL176F and decreased in the following order: mL176F > nmL176 % mWT > nmWT GCAP1 (Fig. 2C and D, Table 2 ).
A third profound alteration of GCAP1 function became apparent when we analysed the x-fold activation (expressed as GC max -GC min divided by GC min ). The mutants showed significantly higher x-fold activation rates than both WT GCAP1 forms. An x-fold activation of 91 for the mL176F mutants ( Fig. 2E and Table 2 ) was the largest we have observed in diseaserelated GCAP1 mutants that we investigated in our laboratory in recent years (16) (17) (18) . The x-fold activation of nmL176F was lower than mL176F, but still higher than mWT GCAP1. Table 2 . Nonmyristoylated (C) and myristoylated (D) GCAP1 variants activate human GC1 at low [Ca 2þ ] yielding values of apparent affinity, EC 50 listed in Table 2 . X-fold activation by GCAP1 variants is shown in panel (E).
addition, we tested the influence of Mg 2þ at physiological concentration in the buffer. Examples of chelator titrations are shown in Fig. 3 ; we employed a three binding sites model for fitting all data, which yielded macroscopic binding constants listed in Table 2 . Two Ca 2þ -binding sites in WT GCAP1 are of high to medium affinity and could easily be detected. Binding to the third binding site occurred with much lower affinity and values were intrinsically less robust due to the detection limit of the assay. We used the two macroscopic binding constants for calculating K app D as previously described (18) ] is half maximal. e X-fold activation is calculated according to GCmax -GCmin divided by GCmin.
Ca 2þ -induced conformational changes and thermal stability of L176F
GCAPs undergo Ca 2þ -induced conformational changes, which trigger a subsequent increase of target GC activities (15, 18) . Conformational changes in the GCAP1 structure can therefore serve as good indicators for dysfunctional features in a mutant (16, 17, 20 . The fluorescence pattern of GCAP1 changed in a biphasic fashion, which is assigned to specific W positions (W21, W54 and W94; ref. 21) . We observed that phase I at low free [Ca 2þ ] up to 1 mM was significantly diminished in mL176F and that fluorescence emission intensities were lower than those of the mWT (Fig. 4B) indicating that the environment of W21 or W54 is altered in the mutant. Phase II above 1 mM [Ca 2þ ] was very similar for all tested variants showing that exposure of W94 to a more hydrophobic environment is similar for WT and mutant. The emission patterns for nmWT and nmL176F were nearly identical. Presence of Mg 2þ reduced the extent of phase I in mWT (21), but to a lesser degree in mL176F. The nonmyristoylated GCAP1 variants showed a nearly identical phase I (data not shown). We further investigated the Mg 2þ /Ca 2þ -induced conformational transitions of both mL176F and nmL176F by circular dichroism (CD) spectroscopy in the far and in the near UV, to monitor respectively changes in the protein secondary and tertiary structure. Results are reported in Fig. 5 (mL176F) and in Supplementary Material, Fig. S2 (nmL176F) . The overall fold of L176F is that of an all a-helix protein ( Fig. 5A ; Supplementary Material, Fig. S2 ), in line with all other GCAP1 mutants analysed so far in our group (17, 18, 22) . Addition of 1 mM Mg 2þ led to changes in far UV ellipticity only for nmL176F (compare Supplementary Material, Fig. S2A with Fig. 5A ), while saturating Ca 2þ led for both cases to an increased ellipticity that is a more negative signal. Quantitative far UV spectral properties observed for both variants in the three analysed states were overall very similar and are reported in Supplementary Material, Table T1 . The selective sensing capability of L176F for the different cations was clearly visible in the near UV spectra initial increase of hydrodynamic size from %6.7 nm up to 6.9 nm (at 30 lM Ca 2þ ), but overall the observed changes were lower compared to mL176F (Fig. 6, gray line) .
Response of L176F to Mg 2þ
While the presence of 1 mM Mg 2þ did not significantly affect the Ca 2þ -affinity of mL176F ( Fig. 3 and Table 2 ), thermal denaturation studies suggest a significant stabilization in the presence of Mg Fig. S4A ). This indicated a lower flexibility of the mutant structure in the GC-inhibiting state, in particular in the entering helix of EF2 and in its cation-binding loop, and in the exiting helix of the EF3 motif. On the contrary, the L176F form with just one Mg 2þ ion bound to EF2 was extremely flexible throughout the primary structure, compared to the WT (Supplementary Material, Fig. S4B ). Interestingly, the EF2 Mg EF3
Mg form showed again a significant rigidity, especially in the Mg 2þ -binding loop of EF2 (Supplementary Material, Fig. S4C ).
While no significant changes in the solvent accessible surface area (data not shown) were detected for L176F compared to the WT in any of the GC-regulatory states, some important differences were observed when analysing the Root-Mean Square Deviation (RMSD). The coordinates of the C a carbons of the essential bidentate Ca 2þ coordinating residues in each EF hand structure, namely E75 (EF2), E111 (EF3) and E155 (EF4) (Fig. 7) were calculated with respect to the pre-production phase in the time-frame of the MD simulations. Results are summarized in the Supplementary Material, 
Discussion
Disturbance of the CGMP-Ca 2þ homeostasis
The L176F substitution had severe consequences for the key regulatory properties of GCAP1: the Ca 2þ -sensitive regulation of the target GC1 was shifted from the submicromolar to the micromolar range, the x-fold activation of the GC by GCAP1 reached a value of 91-fold, and the mutant had an apparent higher affinity than the WT for the GC (Fig. 2) . Peshenko et al. (15) constructed and investigated the L176F mutant in a different context (see also Results section) proposing that the interaction between the myristoyl group and the amino acids in the hydrophobic cavity has a regulatory and therefore functional impact. By screening patients showing clinical symptoms of MD we detected the missense mutation leading to the L176F substitution in the protein. Most of the patients in this study had maculopathy only, although two patients, each from a different family, had some evidence of more widespread photoreceptor involvement. Other reports tend to describe a widespread cone (or cone and rod) involvement (7, 25, 26) , but there are also examples of maculopathy patients in these articles. In other words, there is likely to be a spectrum of phenotypes associated with GUCA1A mutations from maculopathy only to cone or cone-rod dystrophy. The message for clinicians is that a GUCAIA mutation can be a cause of an ad maculopathy as well as a more widespread retinal disease expression. The present study aimed at combining genotype description, phenotype analysis and molecular investigation of protein properties of this MD causing mutation. The disturbed regulation of GC1 by L176F is, at least in part, repeating a pattern often observed with other dystrophy-related GCAP1 mutants (16, 17, (26) (27) (28) (29) (30) (31) . A prominent feature of these cases is that the Ca 2þ -sensitive regulation of GC1 is halfmaximal at higher than normal physiological levels of cytoplasmic [Ca 2þ ] making these mutants constitutionally active, which would dramatically affect the Ca 2þ -cGMP homeostasis in cone and rod cells. However, it is noteworthy that the x-fold activation of the mutant, both the nonmyristoylated and particularly the myristoylated one was very high in comparison to the control WT forms (42-fold and 91-fold, respectively; Fig. 2) . In a cell, expressing a constitutively active mutant the permanent synthesis of cGMP would lead to a high percentage of CNGchannels kept open most of the time, thus allowing the passage of Ca 2þ -ions up to a very high micromolar level. At a certain cytoplasmic [Ca 2þ ] however, the GC activation by the GCAP1 mutant switches back to the non-activated stage and the CNGchannels close during illumination having the consequence Dell'Orco et al. (22) recently modelled the cellular consequences of a photoreceptor cell expressing 50% WT and 50% mutant for other GUCA1A/GCAP1 cone-dystrophy mutations of autosomal dominant inheritance. These investigated mutations shared the constitutive activation profile with L176F and simulated photocurrents showed higher response peak amplitudes, prolongation of response duration and a lower current value after complete photoresponse recovery. However, the overall effects on the photoresponse were not large, but significant enough to cause distortion of normal cell physiology. We predict a similar shaping of the photoresponse in the case of the L176F mutation, but with a stronger impact on the dynamics of the photocurrents ON-and OFF-states due to the more powerful activation rate of L176F.
Is the perturbation of GC activation and Ca 2þ -sensitive regulation due to impaired Ca 2þ -binding of L176F?
Results from chelator assays suggest that L176F is WT-like in terms of affinity for Ca 2þ , similar to what we reported for another GCAP1 mutant L84F (17) . The observed GC perturbation is therefore not due to a reduced Ca 2þ -sensing capability characteristic of most other COD/CORD mutants (17, 18, 31 ) was structurally and dynamically more stable than the form with only one Mg 2þ ion bound to EF2. These results suggest that L176F always harbours a Mg 2þ ion bound to an EF-hand, presumably EF2, and the GC regulatory activity is triggered by cation exchanges in EF3. Moreover, the GC activating state for this mutant seems to be characterized by two Mg 2þ ions bound respectively to EF2 and EF3, at odds with the WT where due to the much lower affinity probably only one Mg 2þ ion is bound to EF2 (23) . Thus, the constitutive activation of GC1 associated with the pathogenic L176F seems to be related to a higher propensity of this variant to bind Mg 2þ rather than to a lower affinity for Ca 2þ , which was the case for many other COD/CORD GCAP1 mutants.
Conformational dynamics of L176F
Impaired Ca 2þ -sensitive function of L176F seems to correlate more to changes in protein conformation than to changes in Ca 2þ -affinity. DLS data showed that L176F conformation dynamically responds to variations in [Ca 2þ ] and its hydrodynamic radius changes until the [Ca 2þ ] is high enough to fully saturate the three protein binding sites. The hydrodynamic diameter of the Ca . Changes for the nonmyristoylated form were however less prominent, in line with what was observed for the WT form (32) .
Molecular dynamics simulations suggest that the structural/ dynamical perturbations introduced by the L176F substitution are not only local and protein flexibility is affected in distal regions. 
Materials and Methods
Patient studies
Patients from 3 families with macular dystrophy were included (Table 1) . Informed consent was obtained; procedures followed the Declaration of Helsinki and had institutional review board approval. All patients underwent a complete eye examination, genetic analyses, as well as specialized tests of retinal and visual function. DNA isolation and Sanger sequencing of the GUCA1A gene was performed as described before (16) .
Cloning, protein expression and purification
The sequence variant c.526T > C (p.L176F) was created by PCR site-directed in vitro mutagenesis (primers available upon request). The amplified PCR product was cut with NdeI and NheI and ligated into the expression vector pET11-bGCAP1-D6 as previously described for other variants (16, 17, 24) . All sequences were verified by DNA sequencing (LGC Genomics, Germany). Heterologous expression of GCAP1 forms was performed in BL21-CodonPlus E. coli cells. Overexpressed proteins were subsequently purified to homogeneity as described before (16, 17, 24) . We co-transformed E.coli cells with the plasmid pBB131 containing the gene for yeast (S. cerevisiae) N-myristoyl transferase to allow posttranslational modification of WT and mutant GCAP1 with a myristoyl group (24) . Proteins were purified after cell lysis using chromatographic procedures exactly as described before for other GCAP1 forms (16, 17, 24) . Methods for determining protein concentration and procedures for gel electrophoresis were done according to standard laboratory protocols exactly as described before (16, 17, 24) .
Cell culture and GC assays
Recombinant human photoreceptor GC1 (assigned as GC-E and alternatively named ROS-GC1, retGC1) was expressed in in HEK flip 293 cells as described (33) . Cell membranes were reconstituted with GCAP1 forms and GC activity was measured as described before (33, 34) . Samples with 10 mM GCAP1 (WT or mutant forms) were incubated at different free [Ca 2þ ] using a Ca 2þ -EGTA buffer system (11, 33, 34 
).
Circular dichroism (CD) spectroscopy and thermal denaturation profiles
CD measurements were performed with a Jasco J-710 spectropolarimeter with a Peltier thermostated cell holder. Reported spectra were subtracted with the spectrum of the buffer (5 mM TrisHCl pH 7.5, 150 mM KCl, 1 mM DTT) and were recorded at 37 C, using the following parameters: scan rate 50 nm/min, bandwidth 1 nm, response time 4 s, accumulations 5. Protein concentration for far UV spectra and thermal denaturations was 5-10 mM in 0.1 cm quartz cuvettes, for near UV it was 22-26 mM in 1 cm quartz cuvettes, measured with Bradford assay (37) . CD spectra were recorded: (1) in the presence of >15-fold EGTA concentration with respect to the protein concentration, (2) after addition of 1 mM MgCl 2 , (3) after addition of 2-fold excess CaCl 2 with respect to the EGTA concentration. Experimental conditions for thermal denaturations between 20 and 96 C were substantially the same as for far UV spectra.
Setting parameters were as follows: wavelength 208 nm, scan rate 1 C/min, data pitch 0.1 C, response time 4 s. Experimental data were fitted for melting temperature estimation to a 4-parameter Hill sigmoid, whose equation is:
Where b f stands for the value of the folded protein, b u for the value of the unfolded protein, T for temperature, H for Hill coefficient and T m for melting temperature.
DLS experiments
DLS measurements were obtained with a Zetasizer Nano-S (Malvern Instruments) using disposable ZEN0112 polystyrene cuvettes. -titration experiments were done on a spectrometer form Photon Technology International (Birmingham, New Jersey, USA) as described before (16, 34) . Data were normalized to the maximal value (16, 34) . Spectra of Mg Protein concentration was 0.3 mM for mWT and mL176F, 0.4lM for nmWT and nmL176F for each titration point. Fluorescence emission intensity was monitored at the wavelength corresponding to the maximal emission of the protein in the sole presence of 100 mM EGTA. Initial Mg 2þ concentration was 9 mM, while it reached 10 mM after complete titration. Due to the experimental set-up we could not absolutely exclude aging of the sample during a titrations set taking place for several hours. Therefore, data were normalized as follows NF ¼ (F-F min )/(F max -F min ), where F is the fluorescence emission at the specific wavelength (340 nm for m/nmWT GCAP1, 342 nm for mL176F, and 343 nm for nmL176F), F min and F max are the minimum and the maximum fluorescence intensity values of the dataset.
Molecular dynamics simulations and analyses
Three-dimensional models and states used for mWT GCAP1 were built using chicken GCAP1 as a template (38) using the same procedure as in (23) . Mutation mL176F was generated in silico using the highest-scored rotamer estimated by the 'mutate residue' function of the Maestro (Schrodinger) software using the modelled mWT GCAP1 as a template. Molecular dynamics simulations were performed using GROMACS 5.0.4 simulation package (39) using the CHARMM27 all-atom force field (40) .
All settings for molecular dynamics simulations were taken from Marino et al. (23) , in which details are provided, with the only difference in the production phase, which in this study consisted of 200 ns of simulations.
Resulting trajectories were subjected to Root-Mean Square Deviation (RMSD) and Root-Mean Square Fluctuations (RMSF) analyses. RMSD of the a-carbon of bidentate Glu residues of EF2, EF3 and EF4 (E75, E111, E155 respectively) was calculated using the 'gmx rms' function implemented in GROMACS 5.0.4 with respect to the starting structure of the production phase. RMSF of the a-carbon of all residues was calculated by the Wordom software (41, 42) , and represents the time averaged-RMSD with respect to the initial structure of the production phase, and is calculated as follows: are the atomic coordinates of a-carbon i at time t j and in the structure after 4 ns equilibration, respectively.
Supplementary Material
Supplementary Material is available at HMG online.
